The Ohio State University Regulatory is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
The Ohio State University Regulatory has participated in 1 clinical trials.
Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State University Regulatory has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State University Regulatory has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).
The Ohio State University Regulatory has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.